glp 1 agonist vs sglt2 inhibitor GLP-1 receptor agonists and inhibitors: a couple at last? Use of GLP-1 Receptor Agonists

Pediatric obesity and MASLD present significant long-term health risks, making early intervention crucial

doi: 10.1111/jdi.14346 51 Petkovi-DabiJBiniICariBBoiLUmievi-ipkaSBednarukNet al

That means going beyond prescriptions to build care plans that integrate nutrition and lifestyle counselingbefore, during, and after the active weight reduction phase

This triple agonist has demonstrated superiority to dual coagonists (GLP-1R/GIPR) and mono-agonists (GLP-1) in reducing body weight (reduction of 25% in 4 weeks), improving glycemic control, and reducing hepatic steatosis in rodent models

This phenomenon has been noted in the cerebrospinal fluid and brain tissue of living PD patients and in postmortem brain autopsies of those with PD

Sustained Impact Weight loss extended for most individuals, even months after discontinuing